Methodological limitations in HIV drug implementation studies help to explain why high-risk individuals are not accessing pre-exposure prophylaxis (PrEP) that can reduce the subsequent risk of HIV infection, according to ...
6 hours ago
1
15
A new study published in the Journal of the International AIDS Society shows that the World Health Organization's (WHO) 2015 recommendation for immediate treatment of all people living with HIV has become the standard of ...
2 hours ago
0
0
Researchers have shown that among users of pre-exposure prophylaxis (PrEP) to prevent against AIDS that includes tenofovir (Truvada), those with daily use—very high adherence—had only about a 1% average decrease in bone ...
2 hours ago
0
1
Cells from the rare individuals who naturally control HIV infection have been the focus of investigation for nearly 15 years with the aim of elucidating their specific features. Following research on the ANRS CO21 CODEX and ...
Jul 12, 2019
1
80
(HealthDay)—There has been a recent increase in the awareness and use of HIV preexposure prophylaxis (PrEP) among men who have sex with men (MSM), according to research published in the July 12 issue of the U.S. Centers ...
Jul 12, 2019
1
0
The prevalence of anal high-grade squamous intraepithelial lesions (HSIL), which precede anal cancer, is much higher in women living with HIV than previously reported, a multi-site, national study involving hundreds of patients ...
Jul 11, 2019
1
0
After decades of failing to develop an effective vaccine against HIV, the federal government has committed $129 million to a new effort led by Scripps Research.
Jul 11, 2019
1
1
Researchers have demonstrated the effectiveness of using algorithms that analyze electronic health records (EHRs) to help physicians identify patients at risk for HIV who may benefit from preexposure prophylaxis (PrEP), which ...
Jul 08, 2019
1
3
